ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
Status:
RECRUITING
Trial end date:
2030-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects that Elranatamab in combination with Lenalidomide and Dexamethasone has on participants that have been newly diagnosed with Multiple Myeloma.